p53-independent functions of the p19(ARF) tumor suppressor

Genes and Development

Volumn 14, Issue 18, 2000, Pages 2358-2365

  Weber, Jason D ^a   Jeffers, John R ^a   Rehg, Jerold E ^a   Randle, David H ^a,b   Lozano, Guillermina ^c   Roussel, Martine F ^a,b   Sherr, Charles J ^a,b   Zambetti, Gerard P ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

ARF; DMP1; Mdm2; p53; Tumor suppression

Indexed keywords

ARF PROTEIN; PROTEIN; PROTEIN MDM2; PROTEIN P19; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE;

ANIMALS; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GENES, TUMOR SUPPRESSOR; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034665749     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.827300     Document Type: Article

References (49)

1. Mdm2 expression is induced by wild-type p53 activity
2. p14(ARF) links the tumor suppressors pRB and p53
3. p16(INK4a) and 9p1(ARF) act in overlapping pathways in cellular immortalization
4. E1A signaling to p53 involves the p19(ARF) tumor suppressor
5. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
6. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
7. The complexity of p53 modulation: Emerging patterns from divergent signals
8. Oncogenic Ras induces p19(ARF) and growth arrest in mouse embryo fibroblasts lacking p21(Cipl) and p27(Kip1) without activating cyclin D-dependent kinases
9. Mdm2 promotes the rapid degradation of p53
10. Versatile retroviral vectors for potential use in gene therapy
11. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6
12. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
13. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of MDM2 for tumor suppressor p53
14. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1
15. Tumor spectrum analysis in p53-mutant mice
16. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF
17. Rescue of embryonic lethality in Mdm-2-deficient mice by absence of p53
18. The p53 gene family
19. Tumor spectrum in ARF-deficient mice
20. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
21. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19(ARF)
22. p53: Puzzle and paradigm
23. Regula-tion of p53 stability by Mdm2
24. Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization
25. Identification of a cryptic nucleolar-localization signal in MDM2
26. Regulation and function of the p53-related proteins: Same family, different rules
27. Twist is a potential oncogene that inhibits apoptosis
28. Loss of one but not two mdm2 null alleles alters the turnout spectrum in p53 null mice
29. Mdm2 deletion does not alter growth characteristics of p53-deficient embryo fibroblasts
30. An N-terminal p14(ARF) peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo
31. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
32. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
33. Oncoprotein MDM2 conceals the activation domain of turnout suppressor p53
34. p19(ARF) links the tumour suppressor p53 to ras
35. The Ink4a tumor suppressor gene product, p19(ARF), interacts with MDM2 and neutralizes MDM2's inhibition of p53
36. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
37. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein
38. Rescue of defective mitogenic signaling by D-type cyclins
39. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
40. Tumor surveillance via the ARF-p53 pathway
41. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 onco-protein
42. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
43. p19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2
44. Cooperative signals governing ARF-Mdm2 interaction and nucleolar localization of the complex
45. Nucleolar Arf sequesters Mdm2 and activates p53
46. The p53-mdm-2 autoregulatory feedback loop
47. MDM2 suppresses p 73 function without promoting p 73 degradation
48. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppressor pathways
49. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization